📋 Tender Overview
Contract awarded for Various medications iii lot-0019, title: caspofunginum 50mg fl pulb. pt. concentrat pt. sol. perf., description: the estimated value of the largest subsequent contract anticipated to be awarded during the framework agreement: 5,226.00 lei excluding vat. estimates of the minimum and maximum quantities that could be requested during the entire framework agreement: minimum quantities 1 fl, maximum quantities 50 fl. estimated calendar (frequency and value of contracts to be awarded): subsequent contracts will be concluded in a cascading manner depending on needs and the financial provisions allocated for this purpose: monthly/semi-annually/quarterly. in the event that the economic operator signing this framework agreement ranked first does not have the capacity to fully respond to the request (inability to ensure the entire requested quantity, non-compliance with the assumed conditions regarding quality, delivery time, price, validity, etc.), the contracting authority will send requests to the occupant of the second place, and in case of denial/lack of response from them, to the occupant of the third place (when the framework agreement is signed with 3 economic operators), following that the operator/operators ranked first, second, and/or third will bear the consequences for non-fulfillment of the obligations assumed, according to the provisions of art.111 para. (2) and (3) of h.g. 395/2016, with subsequent amendments and completions. lot-0027, title: colistinum 1,000,000 ui fl, description: the estimated value of the largest subsequent contract anticipated to be awarded during the framework agreement: 18,459.00 lei excluding vat. estimates of the minimum and maximum quantities that could be requested during the entire framework agreement: minimum quantities 1 fl, maximum quantities 1600 fl. estimated calendar (frequency and value of contracts to be awarded): subsequent contracts will be concluded in a cascading manner depending on needs and the financial provisions allocated for this purpose: monthly/semi-annually/quarterly. in the event that the economic operator signing this framework agreement ranked first does not have the capacity to fully respond to the request (inability to ensure the entire requested quantity, non-compliance with the assumed conditions regarding quality, delivery time, price, validity, etc.), the contracting authority will send requests to the occupant of the second place, and in case of denial/lack of response from them, to the occupant of the third place (when the framework agreement is signed with 3 economic operators), following that the operator/operators ranked first, second, and/or third will bear the consequences for non-fulfillment of the obligations assumed, according to the provisions of art.111 para. (2) and (3) of h.g. 395/2016, with subsequent amendments and completions. lot-0056, title: haloperidolum flacon pic. orale, sol. 2mg/ml, description: the estimated value of the largest subsequent contract anticipated to be awarded during the framework agreement: 32.70 lei excluding vat. estimates of the minimum and maximum quantities that could be requested during the entire framework agreement: minimum quantities 1 fl, maximum quantities 13 fl. estimated calendar (frequency and value of contracts to be awarded): subsequent contracts will be concluded in a cascading manner depending on needs and the financial provisions allocated for this purpose: monthly/semi-annually/quarterly. in the event that the economic operator signing this framework agreement ranked first does not have the capacity to fully respond to the request (inability to ensure the entire requested quantity, non-compliance with the assumed conditions regarding quality, delivery time, price, validity, etc.), the contracting authority will send requests to the occupant of the second place, and in case of denial/lack of response from them, to the occupant of the third place (when the framework agreement is signed with 3 economic operators), following that the operator/operators ranked first, second, and/or third will bear the consequences for non-fulfillment of the obligations assumed, according to the provisions of art.111 para. (2) and (3) of h.g. 395/2016, with subsequent amendments and completions. lot-0097, title: teicoplaninum 400 mg, description: the estimated value of the largest subsequent contract anticipated to be awarded during the framework agreement: 18,271.50 lei excluding vat. estimates of the minimum and maximum quantities that could be requested during the entire framework agreement: minimum quantities 1 fl, maximum quantities 400 fl. estimated calendar (frequency and value of contracts to be awarded): subsequent contracts will be concluded in a cascading manner depending on needs and the financial provisions allocated for this purpose: monthly/semi-annually/quarterly. in the event that the economic operator signing this framework agreement ranked first does not have the capacity to fully respond to the request (inability to ensure the entire requested quantity, non-compliance with the assumed conditions regarding quality, delivery time, price, validity, etc.), the contracting authority will send requests to the occupant of the second place, and in case of denial/lack of response from them, to the occupant of the third place (when the framework agreement is signed with 3 economic operators), following that the operator/operators ranked first, second, and/or third will bear the consequences for non-fulfillment of the obligations assumed, according to the provisions of art.111 para. (2) and (3) of h.g. 395/2016, with subsequent amendments and completions. ii.2.5 award criteria. estimated value excluding vat: 3494.50 ron.Various medications iii